Hong Kong's US$8 billion government fund inks deal with Beijing biotech start-up as city aims for tech hub status [Yahoo! Finance]
Sanofi - American Depositary Shares (SNY)
US:NYSE Investor Relations:
sanofi.com/en/investors
Company Research
Source: Yahoo! Finance
biotechnology firm started by Chinese internet giant Baidu founder Robin Li Yanhong, the fund's second public move as the city seeks to boost its technology sector. The partnership will see Beijing-based Biomap set up an accelerator called BioMap InnoHub, which will aim to support over 50 early-stage research and development (R&D) projects in cutting-edge life science, with priority given to projects recommended by universities and ecosystem partners in Hong Kong, the company said on Monday. The HKIC will not only invest in Biomap, but will also lead its current financing round, meaning that the government fund is "setting the parameters and terms" of this round for other investors to follow, HKIC CEO Clara Chan Ka-chai said at a signing ceremony on Monday. Do you have questions about the biggest topics and trends from around the world? Get the answers with SCMP Knowledge , our new platform of curated content with explainers, FAQs, analyses and infographics brought to you by our
Show less
Read more
Impact Snapshot
Event Time:
SNY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SNY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SNY alerts
High impacting Sanofi - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
SNY
News
- FDA greenlights Regeneron's Dupixent for the treatment of COPD [Yahoo! Finance]Yahoo! Finance
- Regeneron/ Sanofi granted FDA label expansion for Dupixent in COPD Sep. 27, 2024 1:16 PM ET By: Dulan Lokuwithana , SA News Editor [Seeking Alpha]Seeking Alpha
- Sanofi/Regeneron's Dupixent set to dominate COPD biologics market following FDA approval [Yahoo! Finance]Yahoo! Finance
- Press Release: Dupixent approved in the US as the first-ever biologic medicine for patients with COPD [Yahoo! Finance]Yahoo! Finance
- Press Release: Dupixent approved in the US as the first-ever biologic medicine for patients with COPDGlobeNewswire
SNY
Sec Filings
- 9/24/24 - Form 6-K
- 9/13/24 - Form 6-K
- 9/3/24 - Form 6-K
- SNY's page on the SEC website